Literature DB >> 22531821

Induction of carbonyl reductase 1 (CBR1) expression in human lung tissues and lung cancer cells by the cigarette smoke constituent benzo[a]pyrene.

James L Kalabus1, Qiuying Cheng, Raqeeb G Jamil, Erin G Schuetz, Javier G Blanco.   

Abstract

Carbonyl reductase 1 (CBR1) reduces various xenobiotic carbonyl substrates to corresponding alcohol metabolites. Here we demonstrated that benzo[a]pyrene (B[a]P), a potent pro-carcinogen and predominant polycyclic aromatic hydrocarbon (PAH) compound in cigarette smoke and air pollutants, upregulates CBR1 gene expression in vitro and in vivo, and that a proximal xenobiotic response element (XRE) motif (₋₁₂₂XRE) mediates the induction effect of B[a]P. First, we observed 46% and 50% increases in CBR1 mRNA and CBR1 protein levels, respectively, in human lung tissue samples from smokers compared to never-smokers. Second, we detected 3.0-fold (p<0.0001) induction of CBR1 mRNA and 1.5-fold (p<0.01) induction of CBR1 protein levels in cells of the human lung cancer cell line A549 incubated with 2.5 μM B[a]P for 24h. Third, results from experiments with CBR1 promoter constructs indicated that a proximal XRE motif ₋₁₂₂XRE) mediates induction of reporter activity in response to B[a]P. Furthermore, we detected enhanced nuclear translocation of aryl hydrocarbon receptor (AhR) following B[a]P exposure in A549 cells. Finally, we demonstrated increased binding of specific protein complexes to ₋₁₂₂XRE in nuclear extracts from B[a]P-treated cells and the presence of the AhR/Arnt complex in the specific nuclear protein ₋₁₂₂XRE complexes.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22531821      PMCID: PMC3359411          DOI: 10.1016/j.toxlet.2012.04.006

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  33 in total

1.  Expression of the anthracycline-metabolizing enzyme carbonyl reductase 1 in hearts from donors with Down syndrome.

Authors:  James L Kalabus; Carrie C Sanborn; Raqeeb G Jamil; Qiuying Cheng; Javier G Blanco
Journal:  Drug Metab Dispos       Date:  2010-08-20       Impact factor: 3.922

2.  Distribution of mRNAs encoding the arylhydrocarbon receptor, arylhydrocarbon receptor nuclear translocator, and arylhydrocarbon receptor nuclear translocator-2 in the rat brain and brainstem.

Authors:  S L Petersen; M A Curran; S A Marconi; C D Carpenter; L S Lubbers; M D McAbee
Journal:  J Comp Neurol       Date:  2000-11-20       Impact factor: 3.215

3.  Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway.

Authors:  Elizabeth R Macari; Christopher H Lowrey
Journal:  Blood       Date:  2011-04-04       Impact factor: 22.113

4.  Carbonyl reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytosolic enzymes in human liver and lung.

Authors:  E Maser; B Stinner; A Atalla
Journal:  Cancer Lett       Date:  2000-02-01       Impact factor: 8.679

Review 5.  Human carbonyl reductases.

Authors:  Petra Malátková; Edmund Maser; Vladimír Wsól
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

6.  Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.

Authors:  A Atalla; U Breyer-Pfaff; E Maser
Journal:  Xenobiotica       Date:  2000-08       Impact factor: 1.908

7.  Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implications.

Authors:  Alvaro Mordente; Giorgio Minotti; Giuseppe Ettore Martorana; Andrea Silvestrini; Bruno Giardina; Elisabetta Meucci
Journal:  Biochem Pharmacol       Date:  2003-09-15       Impact factor: 5.858

Review 8.  Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals.

Authors:  Michael S Denison; Scott R Nagy
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

9.  Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver.

Authors:  Nina Kassner; Klaus Huse; Hans-Jörg Martin; Ute Gödtel-Armbrust; Annegret Metzger; Ingolf Meineke; Jürgen Brockmöller; Kathrin Klein; Ulrich M Zanger; Edmund Maser; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2008-07-17       Impact factor: 3.922

10.  Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors.

Authors:  Vanessa Gonzalez-Covarrubias; Jianping Zhang; James L Kalabus; Mary V Relling; Javier G Blanco
Journal:  Drug Metab Dispos       Date:  2008-11-20       Impact factor: 3.922

View more
  8 in total

1.  Investigation of the role of DNA methylation in the expression of ERBB2 in human myocardium.

Authors:  Adolfo Quiñones-Lombraña; Rachael Hageman Blair; Javier G Blanco
Journal:  Gene       Date:  2017-07-21       Impact factor: 3.688

2.  Association between CBR1 polymorphisms and NSCLC in the Chinese population.

Authors:  Yong Guo; Yingying Shen; Yongming Xia; Jianzhong Gu
Journal:  Oncol Lett       Date:  2017-09-14       Impact factor: 2.967

3.  Benzo(a)pyrene enhances the EMT-associated migration of lung adenocarcinoma A549 cells by upregulating Twist1.

Authors:  Xi Chen; Hongbing Peng; Jian Xiao; Anqi Guan; Bin Xie; Bixiu He; Qiong Chen
Journal:  Oncol Rep       Date:  2017-08-03       Impact factor: 3.906

4.  Carbonyl reductase 1 catalyzes 20β-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.

Authors:  Ruth A Morgan; Katharina R Beck; Mark Nixon; Natalie Z M Homer; Andrew A Crawford; Diana Melchers; René Houtman; Onno C Meijer; Andreas Stomby; Anna J Anderson; Rita Upreti; Roland H Stimson; Tommy Olsson; Tom Michoel; Ariella Cohain; Arno Ruusalepp; Eric E Schadt; Johan L M Björkegren; Ruth Andrew; Christopher J Kenyon; Patrick W F Hadoke; Alex Odermatt; John A Keen; Brian R Walker
Journal:  Sci Rep       Date:  2017-09-06       Impact factor: 4.379

5.  Little Cigars are More Toxic than Cigarettes and Uniquely Change the Airway Gene and Protein Expression.

Authors:  Arunava Ghosh; Sabri H Abdelwahab; Steven L Reeber; Boris Reidel; Abigail J Marklew; Andrew J Garrison; Shernita Lee; Hong Dang; Amy H Herring; Gary L Glish; Mehmet Kesimer; Robert Tarran
Journal:  Sci Rep       Date:  2017-04-27       Impact factor: 4.379

6.  A distinct lipid metabolism signature of acute myeloid leukemia with prognostic value.

Authors:  Ding Li; Jiaming Liang; Wei Yang; Wenbin Guo; Wenping Song; Wenzhou Zhang; Xuan Wu; Baoxia He
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

7.  MicroRNAs differentially regulate carbonyl reductase 1 (CBR1) gene expression dependent on the allele status of the common polymorphic variant rs9024.

Authors:  James L Kalabus; Qiuying Cheng; Javier G Blanco
Journal:  PLoS One       Date:  2012-11-01       Impact factor: 3.240

8.  Altered gene expression profiles in the lungs of benzo[a]pyrene-exposed mice in the presence of lipopolysaccharide-induced pulmonary inflammation.

Authors:  Q Shi; R R Fijten; D Spina; Y Riffo Vasquez; V M Arlt; R W Godschalk; F J Van Schooten
Journal:  Toxicol Appl Pharmacol       Date:  2017-10-05       Impact factor: 4.219

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.